Cargando…
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges
Neuropeptide Y (NPY) is a 36-amino-acid peptide member of a family also including peptide YY and pancreatic polypeptide, which are all ligands to Gi/Go coupled receptors. NPY regulates several fundamental biologic functions including appetite/satiety, sex and reproduction, learning and memory, cardi...
Autores principales: | Zoccali, Carmine, Ortiz, Alberto, Blumbyte, Inga Arune, Rudolf, Sarina, Beck-Sickinger, Annette G, Malyszko, Jolanta, Spasovski, Goce, Carriazo, Sol, Viggiano, Davide, Kurganaite, Justina, Sarkeviciene, Vaiva, Rastenyte, Daiva, Figurek, Andreja, Rroji, Merita, Mayer, Christopher, Arici, Mustapha, Martino, Gianvito, Tedeschi, Gioacchino, Bruchfeld, Annette, Spoto, Belinda, Rychlik, Ivan, Wiecek, Andrzej, Okusa, Mark, Remuzzi, Giuseppe, Mallamaci, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713155/ https://www.ncbi.nlm.nih.gov/pubmed/34724060 http://dx.doi.org/10.1093/ndt/gfab284 |
Ejemplares similares
-
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease
por: Rroji, Merita, et al.
Publicado: (2022) -
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020) -
The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
por: Figurek, Andreja, et al.
Publicado: (2021) -
FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
por: Figurek, Andreja, et al.
Publicado: (2023) -
Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease
por: Rroji, Merita, et al.
Publicado: (2023)